Global Acute Ischemic Stroke Drugs Market Insights, Forecast to 2028

Q: How big is the acute ischemic stroke drugs market?

Acute Ischemic Stroke CIS also known as Cerebral Infarction CI is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue accompanied by damage to neurons astrocytes oligodendrocytes is the modern society leading to death and disability of the most important central nervous system vascular events.Market Analysis and Insights Global Acute Ischemic Stroke Drugs MarketThe global Acute Ischemic Stroke Drugs market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Tablet accounting for of the Acute Ischemic Stroke Drugs global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

Q: Who are the key players in the acute ischemic stroke drugs market?

Some of the key players are Sanofi, Biogen, Bayer, Pfizer Inc, Roche, Boehringer Ingelheim, Daiichi Sankyo, Bristol–Myers Squibb, Johnson & Johnson, Astrazeneca plc, ZZ Biotech, NoNO Inc, Athersys, SanBio, Sanofi S A, Biogen Inc, Bayer AG, Others.

Code: QYRE-Auto-26N2767

Report

February 2022

Pages:110

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important central nervous system vascular events.

Market Analysis and Insights: Global Acute Ischemic Stroke Drugs Market

The global Acute Ischemic Stroke Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Tablet accounting for % of the Acute Ischemic Stroke Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Acute Ischemic Stroke Drugs market size is valued at US$ million in 2021, while the North America and Europe Acute Ischemic Stroke Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Acute Ischemic Stroke Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Ischemic Stroke Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Ischemic Stroke Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Ischemic Stroke Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Ischemic Stroke Drugs market.

Global Acute Ischemic Stroke Drugs Scope and Market Size

Acute Ischemic Stroke Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Acute Ischemic Stroke Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Tablet

Capsule

Other

Segment by Application

Hospitals

Diagnostic Centers

Others

BY COMPANY

Sanofi

Biogen

Bayer

Pfizer

Roche

Boehringer Ingelheim

Daiichi Sankyo

Bristol-Myers Squibb

Johnson＆Johnson

AstraZeneca

ZZ Biotech

NoNO Inc

Athersys

SanBio

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Tablet

1.2.3 Capsule

1.2.4 Other

1.3 Market by Application

1.3.1 Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Diagnostic Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Acute Ischemic Stroke Drugs Market Perspective (2017-2028)

2.2 Acute Ischemic Stroke Drugs Growth Trends by Region

2.2.1 Acute Ischemic Stroke Drugs Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Acute Ischemic Stroke Drugs Historic Market Size by Region (2017-2022)

2.2.3 Acute Ischemic Stroke Drugs Forecasted Market Size by Region (2023-2028)

2.3 Acute Ischemic Stroke Drugs Market Dynamics

2.3.1 Acute Ischemic Stroke Drugs Industry Trends

2.3.2 Acute Ischemic Stroke Drugs Market Drivers

2.3.3 Acute Ischemic Stroke Drugs Market Challenges

2.3.4 Acute Ischemic Stroke Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acute Ischemic Stroke Drugs Players by Revenue

3.1.1 Global Top Acute Ischemic Stroke Drugs Players by Revenue (2017-2022)

3.1.2 Global Acute Ischemic Stroke Drugs Revenue Market Share by Players (2017-2022)

3.2 Global Acute Ischemic Stroke Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Acute Ischemic Stroke Drugs Revenue

3.4 Global Acute Ischemic Stroke Drugs Market Concentration Ratio

3.4.1 Global Acute Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Drugs Revenue in 2021

3.5 Acute Ischemic Stroke Drugs Key Players Head office and Area Served

3.6 Key Players Acute Ischemic Stroke Drugs Product Solution and Service

3.7 Date of Enter into Acute Ischemic Stroke Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Ischemic Stroke Drugs Breakdown Data by Type

4.1 Global Acute Ischemic Stroke Drugs Historic Market Size by Type (2017-2022)

4.2 Global Acute Ischemic Stroke Drugs Forecasted Market Size by Type (2023-2028)

5 Acute Ischemic Stroke Drugs Breakdown Data by Application

5.1 Global Acute Ischemic Stroke Drugs Historic Market Size by Application (2017-2022)

5.2 Global Acute Ischemic Stroke Drugs Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Acute Ischemic Stroke Drugs Market Size (2017-2028)

6.2 North America Acute Ischemic Stroke Drugs Market Size by Type

6.2.1 North America Acute Ischemic Stroke Drugs Market Size by Type (2017-2022)

6.2.2 North America Acute Ischemic Stroke Drugs Market Size by Type (2023-2028)

6.2.3 North America Acute Ischemic Stroke Drugs Market Share by Type (2017-2028)

6.3 North America Acute Ischemic Stroke Drugs Market Size by Application

6.3.1 North America Acute Ischemic Stroke Drugs Market Size by Application (2017-2022)

6.3.2 North America Acute Ischemic Stroke Drugs Market Size by Application (2023-2028)

6.3.3 North America Acute Ischemic Stroke Drugs Market Share by Application (2017-2028)

6.4 North America Acute Ischemic Stroke Drugs Market Size by Country

6.4.1 North America Acute Ischemic Stroke Drugs Market Size by Country (2017-2022)

6.4.2 North America Acute Ischemic Stroke Drugs Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Acute Ischemic Stroke Drugs Market Size (2017-2028)

7.2 Europe Acute Ischemic Stroke Drugs Market Size by Type

7.2.1 Europe Acute Ischemic Stroke Drugs Market Size by Type (2017-2022)

7.2.2 Europe Acute Ischemic Stroke Drugs Market Size by Type (2023-2028)

7.2.3 Europe Acute Ischemic Stroke Drugs Market Share by Type (2017-2028)

7.3 Europe Acute Ischemic Stroke Drugs Market Size by Application

7.3.1 Europe Acute Ischemic Stroke Drugs Market Size by Application (2017-2022)

7.3.2 Europe Acute Ischemic Stroke Drugs Market Size by Application (2023-2028)

7.3.3 Europe Acute Ischemic Stroke Drugs Market Share by Application (2017-2028)

7.4 Europe Acute Ischemic Stroke Drugs Market Size by Country

7.4.1 Europe Acute Ischemic Stroke Drugs Market Size by Country (2017-2022)

7.4.2 Europe Acute Ischemic Stroke Drugs Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size (2017-2028)

8.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type

8.2.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Type (2017-2028)

8.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application

8.3.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Application (2017-2028)

8.4 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region

8.4.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Acute Ischemic Stroke Drugs Market Size (2017-2028)

9.2 Latin America Acute Ischemic Stroke Drugs Market Size by Type

9.2.1 Latin America Acute Ischemic Stroke Drugs Market Size by Type (2017-2022)

9.2.2 Latin America Acute Ischemic Stroke Drugs Market Size by Type (2023-2028)

9.2.3 Latin America Acute Ischemic Stroke Drugs Market Share by Type (2017-2028)

9.3 Latin America Acute Ischemic Stroke Drugs Market Size by Application

9.3.1 Latin America Acute Ischemic Stroke Drugs Market Size by Application (2017-2022)

9.3.2 Latin America Acute Ischemic Stroke Drugs Market Size by Application (2023-2028)

9.3.3 Latin America Acute Ischemic Stroke Drugs Market Share by Application (2017-2028)

9.4 Latin America Acute Ischemic Stroke Drugs Market Size by Country

9.4.1 Latin America Acute Ischemic Stroke Drugs Market Size by Country (2017-2022)

9.4.2 Latin America Acute Ischemic Stroke Drugs Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size (2017-2028)

10.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type

10.2.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Type (2017-2028)

10.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application

10.3.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Application (2017-2028)

10.4 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country

10.4.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Acute Ischemic Stroke Drugs Introduction

11.1.4 Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.1.5 Sanofi Recent Developments

11.2 Biogen

11.2.1 Biogen Company Details

11.2.2 Biogen Business Overview

11.2.3 Biogen Acute Ischemic Stroke Drugs Introduction

11.2.4 Biogen Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.2.5 Biogen Recent Developments

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Acute Ischemic Stroke Drugs Introduction

11.3.4 Bayer Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.3.5 Bayer Recent Developments

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Acute Ischemic Stroke Drugs Introduction

11.4.4 Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.4.5 Pfizer Recent Developments

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Acute Ischemic Stroke Drugs Introduction

11.5.4 Roche Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.5.5 Roche Recent Developments

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Details

11.6.2 Boehringer Ingelheim Business Overview

11.6.3 Boehringer Ingelheim Acute Ischemic Stroke Drugs Introduction

11.6.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.6.5 Boehringer Ingelheim Recent Developments

11.7 Daiichi Sankyo

11.7.1 Daiichi Sankyo Company Details

11.7.2 Daiichi Sankyo Business Overview

11.7.3 Daiichi Sankyo Acute Ischemic Stroke Drugs Introduction

11.7.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.7.5 Daiichi Sankyo Recent Developments

11.8 Bristol-Myers Squibb

11.8.1 Bristol-Myers Squibb Company Details

11.8.2 Bristol-Myers Squibb Business Overview

11.8.3 Bristol-Myers Squibb Acute Ischemic Stroke Drugs Introduction

11.8.4 Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.8.5 Bristol-Myers Squibb Recent Developments

11.9 Johnson＆Johnson

11.9.1 Johnson＆Johnson Company Details

11.9.2 Johnson＆Johnson Business Overview

11.9.3 Johnson＆Johnson Acute Ischemic Stroke Drugs Introduction

11.9.4 Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.9.5 Johnson＆Johnson Recent Developments

11.10 AstraZeneca

11.10.1 AstraZeneca Company Details

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca Acute Ischemic Stroke Drugs Introduction

11.10.4 AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.10.5 AstraZeneca Recent Developments

11.11 ZZ Biotech

11.11.1 ZZ Biotech Company Details

11.11.2 ZZ Biotech Business Overview

11.11.3 ZZ Biotech Acute Ischemic Stroke Drugs Introduction

11.11.4 ZZ Biotech Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.11.5 ZZ Biotech Recent Developments

11.12 NoNO Inc

11.12.1 NoNO Inc Company Details

11.12.2 NoNO Inc Business Overview

11.12.3 NoNO Inc Acute Ischemic Stroke Drugs Introduction

11.12.4 NoNO Inc Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.12.5 NoNO Inc Recent Developments

11.13 Athersys

11.13.1 Athersys Company Details

11.13.2 Athersys Business Overview

11.13.3 Athersys Acute Ischemic Stroke Drugs Introduction

11.13.4 Athersys Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.13.5 Athersys Recent Developments

11.14 SanBio

11.14.1 SanBio Company Details

11.14.2 SanBio Business Overview

11.14.3 SanBio Acute Ischemic Stroke Drugs Introduction

11.14.4 SanBio Revenue in Acute Ischemic Stroke Drugs Business (2017-2022)

11.14.5 SanBio Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Tablet

Table 3. Key Players of Capsule

Table 4. Key Players of Other

Table 5. Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 6. Global Acute Ischemic Stroke Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 7. Global Acute Ischemic Stroke Drugs Market Size by Region (2017-2022) & (US$ Million)

Table 8. Global Acute Ischemic Stroke Drugs Market Share by Region (2017-2022)

Table 9. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 10. Global Acute Ischemic Stroke Drugs Market Share by Region (2023-2028)

Table 11. Acute Ischemic Stroke Drugs Market Trends

Table 12. Acute Ischemic Stroke Drugs Market Drivers

Table 13. Acute Ischemic Stroke Drugs Market Challenges

Table 14. Acute Ischemic Stroke Drugs Market Restraints

Table 15. Global Acute Ischemic Stroke Drugs Revenue by Players (2017-2022) & (US$ Million)

Table 16. Global Acute Ischemic Stroke Drugs Revenue Share by Players (2017-2022)

Table 17. Global Top Acute Ischemic Stroke Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Ischemic Stroke Drugs as of 2021)

Table 18. Ranking of Global Top Acute Ischemic Stroke Drugs Companies by Revenue (US$ Million) in 2021

Table 19. Global 5 Largest Players Market Share by Acute Ischemic Stroke Drugs Revenue (CR5 and HHI) & (2017-2022)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Acute Ischemic Stroke Drugs Product Solution and Service

Table 22. Date of Enter into Acute Ischemic Stroke Drugs Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Acute Ischemic Stroke Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 25. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2017-2022)

Table 26. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 27. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2023-2028)

Table 28. Global Acute Ischemic Stroke Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 29. Global Acute Ischemic Stroke Drugs Revenue Share by Application (2017-2022)

Table 30. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 31. Global Acute Ischemic Stroke Drugs Revenue Share by Application (2023-2028)

Table 32. North America Acute Ischemic Stroke Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 33. North America Acute Ischemic Stroke Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 34. North America Acute Ischemic Stroke Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 35. North America Acute Ischemic Stroke Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 36. North America Acute Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 37. North America Acute Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 38. Europe Acute Ischemic Stroke Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 39. Europe Acute Ischemic Stroke Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 40. Europe Acute Ischemic Stroke Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 41. Europe Acute Ischemic Stroke Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 42. Europe Acute Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 43. Europe Acute Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 44. Asia Pacific Acute Ischemic Stroke Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 45. Asia Pacific Acute Ischemic Stroke Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 46. Asia Pacific Acute Ischemic Stroke Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 47. Asia Pacific Acute Ischemic Stroke Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 48. Asia Pacific Acute Ischemic Stroke Drugs Market Size by Region (2017-2022) & (US$ Million)

Table 49. Asia Pacific Acute Ischemic Stroke Drugs Market Size by Region (2023-2028) & (US$ Million)

Table 50. Latin America Acute Ischemic Stroke Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 51. Latin America Acute Ischemic Stroke Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 52. Latin America Acute Ischemic Stroke Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 53. Latin America Acute Ischemic Stroke Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 54. Latin America Acute Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 55. Latin America Acute Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 56. Middle East and Africa Acute Ischemic Stroke Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 57. Middle East and Africa Acute Ischemic Stroke Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 58. Middle East and Africa Acute Ischemic Stroke Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 59. Middle East and Africa Acute Ischemic Stroke Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 60. Middle East and Africa Acute Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 61. Middle East and Africa Acute Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 62. Sanofi Company Details

Table 63. Sanofi Business Overview

Table 64. Sanofi Acute Ischemic Stroke Drugs Product

Table 65. Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 66. Sanofi Recent Developments

Table 67. Biogen Company Details

Table 68. Biogen Business Overview

Table 69. Biogen Acute Ischemic Stroke Drugs Product

Table 70. Biogen Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 71. Biogen Recent Developments

Table 72. Bayer Company Details

Table 73. Bayer Business Overview

Table 74. Bayer Acute Ischemic Stroke Drugs Product

Table 75. Bayer Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 76. Bayer Recent Developments

Table 77. Pfizer Company Details

Table 78. Pfizer Business Overview

Table 79. Pfizer Acute Ischemic Stroke Drugs Product

Table 80. Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 81. Pfizer Recent Developments

Table 82. Roche Company Details

Table 83. Roche Business Overview

Table 84. Roche Acute Ischemic Stroke Drugs Product

Table 85. Roche Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 86. Roche Recent Developments

Table 87. Boehringer Ingelheim Company Details

Table 88. Boehringer Ingelheim Business Overview

Table 89. Boehringer Ingelheim Acute Ischemic Stroke Drugs Product

Table 90. Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 91. Boehringer Ingelheim Recent Developments

Table 92. Daiichi Sankyo Company Details

Table 93. Daiichi Sankyo Business Overview

Table 94. Daiichi Sankyo Acute Ischemic Stroke Drugs Product

Table 95. Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 96. Daiichi Sankyo Recent Developments

Table 97. Bristol-Myers Squibb Company Details

Table 98. Bristol-Myers Squibb Business Overview

Table 99. Bristol-Myers Squibb Acute Ischemic Stroke Drugs Product

Table 100. Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 101. Bristol-Myers Squibb Recent Developments

Table 102. Johnson＆Johnson Company Details

Table 103. Johnson＆Johnson Business Overview

Table 104. Johnson＆Johnson Acute Ischemic Stroke Drugs Product

Table 105. Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 106. Johnson＆Johnson Recent Developments

Table 107. AstraZeneca Company Details

Table 108. AstraZeneca Business Overview

Table 109. AstraZeneca Acute Ischemic Stroke Drugs Product

Table 110. AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 111. AstraZeneca Recent Developments

Table 112. ZZ Biotech Company Details

Table 113. ZZ Biotech Business Overview

Table 114. ZZ Biotech Acute Ischemic Stroke Drugs Product

Table 115. ZZ Biotech Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 116. ZZ Biotech Recent Developments

Table 117. NoNO Inc Company Details

Table 118. NoNO Inc Business Overview

Table 119. NoNO Inc Acute Ischemic Stroke Drugs Product

Table 120. NoNO Inc Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 121. NoNO Inc Recent Developments

Table 122. Athersys Company Details

Table 123. Athersys Business Overview

Table 124. Athersys Acute Ischemic Stroke Drugs Product

Table 125. Athersys Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 126. Athersys Recent Developments

Table 127. SanBio Company Details

Table 128. SanBio Business Overview

Table 129. SanBio Acute Ischemic Stroke Drugs Product

Table 130. SanBio Revenue in Acute Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)

Table 131. SanBio Recent Developments

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Acute Ischemic Stroke Drugs Market Share by Type: 2021 VS 2028

Figure 2. Tablet Features

Figure 3. Capsule Features

Figure 4. Other Features

Figure 5. Global Acute Ischemic Stroke Drugs Market Share by Application: 2021 VS 2028

Figure 6. Hospitals Case Studies

Figure 7. Diagnostic Centers Case Studies

Figure 8. Others Case Studies

Figure 9. Acute Ischemic Stroke Drugs Report Years Considered

Figure 10. Global Acute Ischemic Stroke Drugs Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 11. Global Acute Ischemic Stroke Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Acute Ischemic Stroke Drugs Market Share by Region: 2021 VS 2028

Figure 13. Global Acute Ischemic Stroke Drugs Market Share by Players in 2021

Figure 14. Global Top Acute Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Ischemic Stroke Drugs as of 2021)

Figure 15. The Top 10 and 5 Players Market Share by Acute Ischemic Stroke Drugs Revenue in 2021

Figure 16. North America Acute Ischemic Stroke Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 17. North America Acute Ischemic Stroke Drugs Market Size Market Share by Type (2017-2028)

Figure 18. North America Acute Ischemic Stroke Drugs Market Size Market Share by Application (2017-2028)

Figure 19. North America Acute Ischemic Stroke Drugs Market Size Share by Country (2017-2028)

Figure 20. United States Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Canada Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Europe Acute Ischemic Stroke Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 23. Europe Acute Ischemic Stroke Drugs Market Size Market Share by Type (2017-2028)

Figure 24. Europe Acute Ischemic Stroke Drugs Market Size Market Share by Application (2017-2028)

Figure 25. Europe Acute Ischemic Stroke Drugs Market Size Share by Country (2017-2028)

Figure 26. Germany Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. France Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. U.K. Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Italy Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Russia Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Nordic Countries Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Asia-Pacific Acute Ischemic Stroke Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 33. Asia Pacific Acute Ischemic Stroke Drugs Market Size Market Share by Type (2017-2028)

Figure 34. Asia Pacific Acute Ischemic Stroke Drugs Market Size Market Share by Application (2017-2028)

Figure 35. Asia Pacific Acute Ischemic Stroke Drugs Market Size Share by Region (2017-2028)

Figure 36. China Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. Japan Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. South Korea Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Southeast Asia Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. India Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Australia Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 42. Latin America Acute Ischemic Stroke Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 43. Latin America Acute Ischemic Stroke Drugs Market Size Market Share by Type (2017-2028)

Figure 44. Latin America Acute Ischemic Stroke Drugs Market Size Market Share by Application (2017-2028)

Figure 45. Latin America Acute Ischemic Stroke Drugs Market Size Share by Country (2017-2028)

Figure 46. Mexico Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Brazil Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Middle East & Africa Acute Ischemic Stroke Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 49. Middle East and Africa Acute Ischemic Stroke Drugs Market Size Market Share by Type (2017-2028)

Figure 50. Middle East and Africa Acute Ischemic Stroke Drugs Market Size Market Share by Application (2017-2028)

Figure 51. Middle East and Africa Acute Ischemic Stroke Drugs Market Size Share by Country (2017-2028)

Figure 52. Turkey Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. Saudi Arabia Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. UAE Acute Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. Sanofi Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 56. Biogen Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 57. Bayer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 58. Pfizer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 59. Roche Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 60. Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 61. Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 63. Johnson＆Johnson Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 64. AstraZeneca Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 65. ZZ Biotech Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 66. NoNO Inc Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 67. Athersys Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 68. SanBio Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2017-2022)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Acute Ischemic Stroke Drugs Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-26N2767

Global Acute Ischemic Stroke Drugs Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions